Propoxyphene Napsylate
C22H29NO2·C10H8O3S·H2O
565.72
Benzeneethanol,a-[2-(dimethylamino)-1-methylethyl]-a-phenyl-,propanoate (ester),[S-(R*,S*)]-,compd.with 2-naphthalenesulfonic acid (1:1),monohydrate. (aS,1R)-a-[2-(Dimethylamino)-1-methylethyl]-a-phenylphenethyl propionate compound with 2-naphthalenesulfonic acid (1:1)monohydrate [26570-10-5]. Anhydrous 547.72 [17140-78-2]. »Propoxyphene Napsylate contains not less than 97.0percent and not more than 103.0percent of C22H29NO2·C10H8O3S,calculated on the anhydrous basis.
Packaging and storage
Preserve in tight containers.
USP Reference standards á11ñ
USPa-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane RS.USP Propoxyphene Napsylate RS.USP Propoxyphene Related Compound A RS.
Identification
A:
Infrared Absorption á197Kñ:previously dried at 105for 3hours.
B:
Ultraviolet Absorption á197Uñ
Solution:
40µg per mL.
Medium:
methanol.
Absorptivities at 275nm,calculated on the anhydrous basis,do not differ by more than 3.0%.
Melting range,Class Iá741ñ:
between 158and 165,but the range between beginning and end of melting does not exceed 4,determined after drying at 105for 3hours.
Specific rotation á781Sñ:
between +35and +43.
Test solution:
10mg per mL,in chloroform.
Water,Method Iá921ñ:
between 2.5%and 5.0%.
Residue on ignition á281ñ:
not more than 0.5%.
Heavy metals,Method IIá231ñ:
0.003%.
Change to read:
Related compounds
Mobile phaseand Chromatographic system
Proceed as directed in theAssay.
Standard stockUSP28solution
Accurately weighUSP28about 10mg each of USP Propoxyphene Related Compound A RSand USPa-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane RSintoUSP28a 50-mLvolumetric flask,dissolve using 2mLof methanol,USP28dilute withMobile phase to volume,and mix.
Standard solution
Transfer 5.0mLof the Standard stock solution to a 50-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.USP28
System suitability solution
Transfer 1.0mLof the Standard stock solutionto a 10.0-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.USP28
Test solution
Use theAssay preparation.
Chromatographic system
Chromatograph theSystem suitability solution,and record the peak responses as directed forProcedure:the relative retention times are about 0.63for propoxyphene related compound A,0.78for a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane,and 1.0for propoxyphene napsylate;the resolution,R,between a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane and propoxyphene related compound AUSP28is not less than 2.0;USP28and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 50µL)of the Standard solutionand theUSP28Test solution into the chromatograph,record the chromatograms,and measure the peak responses.Calculate the quantity,in mg,USP28of propoxyphene related compound AUSP28in the portion of Propoxyphene Napsylate taken by the formula:
50C(491.67/319.88)(rU/rS),
in which Cis the concentration,in mg per mL,of USP Propoxyphene Related Compound A RSin the Standard solution;491.67and 319.88are the molecular weights of propoxyphene related compound Anapsylate and propoxyphene related compound A,respectively;and rUand rSare the propoxyphene related compound Apeak responses obtained from the Test solutionand the Standard solution,respectively:not more than 0.5%of propoxyphene related compound Anapsylate is found.USP28Calculate the quantity,in mg,USP28of a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane napsylate in the portion of Propoxyphene Napsylate taken by the formula:
50C(533.71/325.45)(rU/rS),
in which Cis the concentration,in mg per mL,of USPa-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane RSin the Standard solution;533.71and 325.45are the molecular weights of a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane napsylate and a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane,respectively;and rUand rSare the a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane peak responses obtained from the Test solutionand the Standard solution,respectively.USP28Not more than 0.6%of a-d-2-acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane napsylate is found.
Organic volatile impurities,Method Vá467ñ:
meets the requirements.
Solvent
Use dimethyl sulfoxide.
Change to read:
Assay
0.1MUSP28Monobasic ammonium phosphate buffer,pH6.3
Dissolve 11.5g of monobasic ammonium phosphate and 1.0mLof triethylamine in 1000mLof water,adjust with 10%sodium hydroxide to a pHof 6.3±0.05,and mix.
Mobile phase
Prepare a filtered and degassed mixture of methanol and 0.1MUSP28Monobasic ammonium phosphate buffer,pH6.3(67:33).Make adjustments if necessary (seeSystem Suitability underChromatography á621ñ).
Standard preparation
Dissolve an accurately weighed quantity of USP Propoxyphene Napsylate RSinMobile phase to obtain a solution having a known concentration of about 5.0mg per mL.
Assay preparation
Transfer about 250mg of Propoxyphene Napsylate,accurately weighed,to a 50-mLvolumetric flask,dissolve in and dilute withMobile phase to volume,and mix.
Chromatographic system(see Chromatography á621ñ)
The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm ×30-cm column that contains packing L1.The flow rate is about 1.5mLper minute.Chromatograph theStandard preparation,and record the peak responses as directed forProcedure:the retention time of propoxyphene napsylate is about 9minutes;the tailing factor for the propoxyphene napsylate peak is not more than 3.5;USP28and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 50µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of C22H29NO2·C10H8O3Sin the portion of Propoxyphene Napsylate taken by the formula:
50C(rU/rS),USP28
in whichCis the concentration,in mg per mL,of USP Propoxyphene Napsylate RSin theStandard preparation;andrUandrSare the peak responses obtained from theAssay preparation and theStandard preparation,respectively.
Auxiliary Information
Staff Liaison:Daniel K.Bempong,Ph.D.,Scientist
Expert Committee:(PA2)Pharmaceutical Analysis 2
USP28NF23Page 1655
Pharmacopeial Forum:Volume No.30(3)Page 927
Phone Number:1-301-816-8143
|